Last reviewed · How we verify
NCT03181906
Effectiveness of Pre-Consultation Medication Reconciliation Service in Reducing Unintentional Medication Discrepancies During Transition of Care From Hospital Discharge to Primary Care Setting
NA trial testing Pre-Consultation Medication Reconciliation in Medication Administered in Error in 200 participants. Completed in 30 April 2017.
28 February 2017
Quick facts
| Lead sponsor | National Healthcare Group, Singapore |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 200 |
| Start date | 11 March 2016 |
| Primary completion | 28 February 2017 |
| Estimated completion | 30 April 2017 |
Drugs / interventions tested
- Pre-Consultation Medication Reconciliation
Conditions studied
- Medication Administered in Error — all drugs for Medication Administered in Error →
- Medication Adherence — all drugs for Medication Adherence →
Sponsor
National Healthcare Group, Singapore
Who can join
21 and older, any sex, with Medication Administered in Error or Medication Adherence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the the effectiveness of pre-consultation Medication Reconciliation Service in reducing unintentional medication discrepancies among patients who discharged from hospital to primary care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03181906
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Medication Administered in Error
Currently open trials in the same condition.
- NCT05761847 — Pediatric Medication Therapy Management Trial · NA · recruiting
Other National Healthcare Group, Singapore trials
Trials by the same sponsor.
- NCT05410691 — Handheld Ultrasound-guided Cannulation of Difficult Haemodialysis Arteriovenous Access by Renal Nurses · NA · completed
- NCT06802679 — Comparison of Standard Versus High Dose Urokinase for Dysfunctional Tunneled Dialysis Catheters in Haemodialysis Patient · Phase 4 · completed
- NCT06022835 — Chlorhexidine Gluconate-gel Dressing for Exit Site Infection in Peritoneal Dialysis · NA · completed
- NCT03273140 — The Effectiveness of Gamification Diabetes Education Program for Poorly Controlled Type 2 Diabetic Patients · NA · completed
- NCT01257711 — A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03181906 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Healthcare Group, Singapore
- Last refreshed: 9 June 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03181906.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing